Apremilast in the Treatment of Uveitis

NCT00889421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Investigator discretion due to lack of efficacy in three subjects enrolled

Conditions

Uveitis

Interventions

DRUG: Apremilast

Sponsor

Oregon Health and Science University

Collaborators

[object Object]